Literature DB >> 1491745

Neuroimmunology of Alzheimer's disease: a conference report.

D W Dickson1, J Rogers.   

Abstract

A multidisciplinary group met under the auspices of the National Institute on Aging and the Dell Foundation at the Princess Resort in San Diego, CA on April 5-6, 1991. The meeting was organized by Dr. Caleb E. Finch, University of Southern California, Dr. Zaven Khachaturian, National Institute on Aging, Dr. William Markesbery, University of Kentucky, Dr. Patrick McGeer, University of British Columbia, and Dr. Joseph Rogers, Institute for Biogerontology Research, and covered recent data suggesting neuroimmune correlates of Alzheimer's disease (AD). These findings span many of the major immune system phenomena, from major histocompatibility complex (MHC) antigens through cytokines and the complement cascade and suggest that some facets of AD pathogenesis may be immune related.

Entities:  

Mesh:

Year:  1992        PMID: 1491745     DOI: 10.1016/0197-4580(92)90104-6

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  10 in total

1.  Immunocytochemical detection of anti-hippocampal antibodies in Alzheimer's disease and normal cerebrospinal fluid.

Authors:  D A Loeffler; P L Juneau; H U Nguyen; D Najman; N Pomara; P A LeWitt
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

Review 2.  Proteoglycans and the acute-phase response in Alzheimer's disease brain.

Authors:  B Leveugle; H Fillit
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

3.  Measurement of acute phase proteins in the rat brain: contribution of vascular contents.

Authors:  D A Loeffler; M C Linder; M Zamany; E Harel; M A Paul; H Baumann; P A LeWitt
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

4.  Characterization of ionotropic glutamate receptors in human lymphocytes.

Authors:  G Lombardi; C Dianzani; G Miglio; P L Canonico; R Fantozzi
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

Review 5.  Cognitive enhancement therapy for Alzheimer's disease. The way forward.

Authors:  L Parnetti; U Senin; P Mecocci
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

Review 6.  Neuropathology of Alzheimer's disease.

Authors:  Daniel P Perl
Journal:  Mt Sinai J Med       Date:  2010 Jan-Feb

Review 7.  Transcranial near-infrared light in treatment of neurodegenerative diseases.

Authors:  Damir Nizamutdinov; Chibueze Ezeudu; Erxi Wu; Jason H Huang; S Stephen Yi
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

8.  Inflammatory process in Alzheimer's Disease.

Authors:  Marco A Meraz-Ríos; Danira Toral-Rios; Diana Franco-Bocanegra; Juana Villeda-Hernández; Victoria Campos-Peña
Journal:  Front Integr Neurosci       Date:  2013-08-13

9.  Decreased Expression of Sulfatase 2 in the Brains of Alzheimer's Disease Patients: Implications for Regulation of Neuronal Cell Signaling.

Authors:  Rosebud O Roberts; Yoo Na Kang; Chunling Hu; Catherine D Moser; Shaoqing Wang; Michael J Moore; Rondell P Graham; Jin-Ping Lai; Ronald C Petersen; Lewis R Roberts
Journal:  J Alzheimers Dis Rep       Date:  2017-09-28

Review 10.  The Glymphatic System (En)during Inflammation.

Authors:  Frida Lind-Holm Mogensen; Christine Delle; Maiken Nedergaard
Journal:  Int J Mol Sci       Date:  2021-07-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.